New patent for Intra-cellular drug CAPLYTA

   September 12, 2023    Comments Off on New patent for Intra-cellular drug CAPLYTA    Posted in: Patent Added

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting…

The post New patent for Intra-cellular drug CAPLYTA appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog